Apogenix AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2005-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.apogenix.com
Clinical Trials
8
Active:5
Completed:1
Trial Phases
3 Phases
Phase 1:5
Phase 2:1
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (62.5%)Phase 3
2 (25.0%)Phase 2
1 (12.5%)Asunercept in Patients With Severe COVID-19
Phase 2
Completed
- Conditions
- COVID-19 Induced PneumoniaCovid19
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- Apogenix AG
- Target Recruit Count
- 438
- Registration Number
- NCT04535674
- Locations
- 🇷🇺
Republican Clinical Infectious Hospital n.a. professor A.F. Agafonov, Kazan, Russian Federation
🇷🇺Scientific Research lnstitute fоr Соmрlех lssues of Cardiovascular Diseases, Kemerovo, Russian Federation
🇷🇺Federal State Budgetary Educational Institution of Higher Education "Kuban State Medical University" of the Ministry of Health of the Russian Federation, Krasnodar, Russian Federation
News
No news found